GlassScriptPhysician profile
Traci Taylor
NPI 1811514003
$7,611.13
in general payments reported to CMS, 2019-2025
43 companies · $2,054 in 2025
The $2,054 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $945 · 2022: $1,657 · 2023: $1,172 · 2024: $1,783 · 2025: $2,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,009.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,008.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,378.35 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $802.05 | 2021-2025 | Evenity, Repatha, Otezla |
| Abbvie INC. | $644.67 | 2021-2025 | |
| Lilly USA, LLC | $536.24 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $429.41 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $356.97 | 2021-2024 | Airsupra, Breztri |
| Novartis Pharmaceuticals Corporation | $356.06 | 2022-2024 | |
| Otsuka America Pharmaceutical, INC. | $354.64 | 2023-2025 | Rexulti, Nuedexta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $281.93 | 2021-2024 | Jardiance |
| Esperion Therapeutics, INC. | $258.64 | 2021-2025 | Nexletol |
| Merck Sharp & Dohme LLC | $217.43 | 2021-2025 | Gardasil 9, Capvaxive, Verquvo |
| Dexcom, INC. | $167.57 | 2023-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $166.45 | 2022-2025 | |
| Amarin Pharma, INC. | $158.64 | 2021-2022 | |
| Lundbeck LLC | $147.52 | 2023-2025 | Rexulti |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Traci Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.